Excerpts

After 2 d of HFD, the expressions of Il-7 and Ebf-1, critical to early B-cell development, were down −20% ( P = 0.08) and −11% ( P = 0.06), while Pax-5 expression, a marker indicating an intermediate stage of development, showed only a slight trend in reduction relative to RD (−9%; p = 0.18).

Comparing the spatially averaged temporal standard deviation of the residual error signal, whole-brain values for DORK+dPLACE+DMA were significantly reduced compared to those obtained with baseline post-processing (p < 0.05); and showed a trend toward reduction when compared to use of sPLACE (p = 0.18).

Again, no interactions involving memory and SF approached significance (SF×memory (F(1,15) = 2.0, p = .18), SF×memory×ISI (F(1,15) = 1.4, p = .25), SF×memory×target presence (F(1,15) = .41, p = .53)).

While the following results are not statistically significant, analysis of randomly assigned upper size limits identified a slight trend of peak support at 40”, where the majority of participants displayed positive or neutral opinions ( P = 0.18, Fig 4b ).

There was a slight trend in the same direction for median TTF in the low TS expression group to the high expression group (12.3 vs.11.7 mo, HR 0.82, 95% CI: 0.33 to 2.0, Log-rank p = 0.18) that did not reach statistical significance.

TNF-alpha expression was positively correlated with airway bacterial burden (r = 0.41, p<0.01, q<0.05) and negatively correlated with phylogenetic diversity (r = −0.29, p<0.05, q<0.05), though the relationship with community richness did not quite reach significance (r = −0.19, p = 0.18, q = 0.09; Figure 2 ).

However post hoc analysis ( Fig 4C ) revealed that the PDGF-BB treated cells remained a statistical trend (p = 0.18).

Calculating overall survival starting with the first diagnosis of metastasis, patients carrying a B-RAF mutation revealed a trend to a decreased survival compared to patients with wildtype B-RAF (p = 0.052, tissues; p = 0.072, cell lines), whereas patients carrying an N-RAS mutation showed a trend towards a favorable survival compared to patients without N-RAS mutation (p = 0.18, tissues; p = 0.12, cell lines).

There was a nonsignificant trend toward increased overexpression of HER2 in HGD lesions (5.3% vs. 0.0%, p = 0.187) ( Fig 2 ).

However, for aD NDF and aD ADF, particularly stomach type approached significance in both models, and body mass in the model for aD ADF (whole model: R 2 = 0.170, p = 0.187 and R 2 = 0.252, p = 0.074; body mass F = 2.252, p = 0.150 and F = 3.025, p = 0.074; stomach type: F = 3.866, p = 0.064 and F = 3.025, p = 0.074, respectively).

Although not significant, there was a trend towards significance for MCOLN1 risk variants in LBD ( p = 0.189) and ADLBV ( p = 0.072).

0.87±0.24 in CC/CG p = 0.87), even if a weak trend was observed in patients <50 years (0.79±0.21 in GG vs. 0.72±0.19 in CC/CG, p = 0.19) ( Figure 1C ).

Even though there was a weak trend for association of the insulin-desensitizing minor A-allele of FNDC5 SNP rs726344 with higher FNDC5 mRNA contents (p = 0.19), this SNP’s MAF was too low to allow a reliable evaluation (only four heterozygous and no homozygous carriers of the minor allele were present among the myotube donors).

The only results approaching borderline significance concerned comparisons between averaged AI and poor health status in the overall GNKQ-R (P = .19), Section 1 (P = .07), and Section 4 (P = .10).

Although the pre-treatment analysis did not yield any significant p-values, perhaps due to the small sample size of the pre-treatment high risk group, a total of 54 miRNAs approached significance (p = 0.19).

When applying a cluster based randomization test including all sensors, there was a weak trend (55–65 Hz, 0.0–3.0 s, p = 0.19).

Twenty-eight patients with at least minimal response showed a trend toward lower detection rate of MYD88 L265P mutation (25.0% vs. 66.7%, P = 0.19) and mutant allele burden (median, 0.00% vs. 0.22%, P = 0.07), compared to 3 patients less than minimal response.

In the adjusted logistic regression model for delirium, nurse-led management showed a nonsignificant trend toward reduced delirium (adjusted OR, 0.58; 95% CI, 0.26–1.30; P = 0.190) ( Table 5 ).

Performance in this task and reading competence showed a weak trend of positive correlation ( r = 0.24, p = 0.19).

(e) On doing this, the MV skew became stronger than for raw data in the present dataset, but this is of less concern; the Mardia kurtosis that was highly significant in the raw values, though still positive (1.3) became NS (p=0.19) on the residuals.

Although the trends are clear, because of the limited sample size of the cohort of patients for which follow-up data were available (A-L group n = 13; C-L group n = 11), the differences are marginally insignificant (p<0.191, logrank test).

Although none of the interactions was close to significance (all F < 1.50, p > .192), indicating congruency in all contingency conditions, we again tested our predictions for the different contingency types by separately assessing congruency effects.

We evaluated several clinical variables and their influence on CD8 + T-cell reconstitution, and none of them correlated significantly with faster CD8 + T-cell reconstitution at the time point of 28 days post-transplant, although there was a slight trend towards faster CD8 + T-cell recovery in patients with higher CD34 + -cell dose in the graft (P = 0.20).

Variables in the multivariate analysis were selected based on variables which were marginally significant with P<0.20 in univariate analysis.

Combinational treatment showed significance in comparison to control by week five (p = 0.029), curcumin alone showed a trend toward significance (p = 0.20), and NSC treatment showed no significance (p = 0.55).